Theriva Biologics, Inc. Class of Warrant or Right, Outstanding
Theriva Biologics, Inc. (TOVX) had Class of Warrant or Right, Outstanding of 0 shares as of 2023-10-31, per its 10-K filed 2025-03-06.
Financial Statements › Notes
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2025-03-06
- 2023-10-31: Class of Warrant or Right, Outstanding 0.00 shares.
- 2018-10-10: Class of Warrant or Right, Outstanding 13.67M shares.
- 2016-12-31: Class of Warrant or Right, Outstanding 311.83K shares.
- 2015-12-31: Class of Warrant or Right, Outstanding 311.83K shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2023-10-31 | 0.00 shares 10-K · filed 2025-03-06 |
| 2018-10-10 | 13.67M shares 10-K · filed 2021-03-04 |
| 2016-12-31 | 311.83K shares 10-K · filed 2017-03-02 |
| 2015-12-31 | 311.83K shares 10-K · filed 2016-03-10 |
| 2015-03-31 | 316.52K shares 10-Q · filed 2015-05-11 |
| 2014-12-31 | 316.52K shares 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |